Molecular profiling for lymphoma
Research type
Research Study
Full title
Molecular profiling for lymphoma
IRAS ID
152982
Contact name
Peter Johnson
Contact email
Research summary
This study is being set up in order to permit prospective molecular typing of samples of non-Hodgkin lymphoma from surplus material obtained at routine biopsies. It is intended to facilitate identification of patients for whom molecular targeted therapies may be available. The results of molecular typing will be returned to the clinical team caring for the patient, in order to make them aware of specific abnormalities which would make specific targeted therapy an option within a clinical trial.
REC name
North West - Liverpool Central Research Ethics Committee
REC reference
14/NW/1128
Date of REC Opinion
8 Jul 2014
REC opinion
Favourable Opinion